Brief: Active Biotech Q4 Operating Loss Narrows To SEK 15.2 Million
09/02/2023 07:35
Feb 9 (Reuters) - Active Biotech AB publ ACTI.ST :
* Q4 OPERATING LOSS SEK 15.2 MILLION VERSUS LOSS SEK 16.1
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN8bbv2v
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million